Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study-Reference-Cited by-同舟云学术

Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study

Published:2021-12 Issue:12 Volume:22 Page:1777-1786
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Qian David C,Kleber Troy,Brammer Brianna,Xu Karen M,Switchenko Jeffrey M,Janopaul-Naylor James R,Zhong Jim,Yushak Melinda L,Harvey R Donald,Paulos Chrystal M,Lawson David H,Khan Mohammad K,Kudchadkar Ragini R,Buchwald Zachary S

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Oncology

Reference37 articles.

1. The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy;Havel;Nat Rev Cancer,2019

2. Circadian rhythms in adaptive immunity;Downton;Immunology,2020

3. Molecular mechanisms and physiological importance of circadian rhythms;Patke;Nat Rev Mol Cell Biol,2020

4. Clocking in to immunity;Scheiermann;Nat Rev Immunol,2018

5. Cortisol and epinephrine control opposing circadian rhythms in T cell subsets;Dimitrov;Blood,2009

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of a circadian-based prognostic signature predicting cancer-associated fibroblasts infiltration and immunotherapy response in bladder cancer;Aging;2024-08-30

2. Immune checkpoint inhibitor infusion times and clinical outcomes in patients with melanoma;The Oncologist;2024-08-27

3. Association between dichotomized VASARI feature and overall survival in glioblastoma patients: a single-institution propensity score matching analysis;Cancer Imaging;2024-08-18

4. Efficacy of timing‑dependent infusion of nivolumab in patients with advanced gastric cancer;Oncology Letters;2024-07-29

5. Recent advances in immunotherapy and its combination therapies for advanced melanoma: a review;Frontiers in Oncology;2024-07-16